Advertisement

Topics

Bluebird Reports Early Results From Upgraded Gene Therapy

07:00 EDT 23 Jun 2017 | Xconomy

One of the year’s most closely watched clinical studies could lead to a landmark approval of a gene therapy and throw wide open the debate over how to pay for expensive drugs. The first drips of data have emerged. Bluebird Bio (NASDAQ: BLUE) says the first three patients—of 15 total expected—have had good results from […]

Original Article: Bluebird Reports Early Results From Upgraded Gene Therapy

NEXT ARTICLE

More From BioPortfolio on "Bluebird Reports Early Results From Upgraded Gene Therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...